H

HK Inno.N Corp
KOSDAQ:195940

Watchlist Manager
HK Inno.N Corp
KOSDAQ:195940
Watchlist
Price: 51 500 KRW -0.19% Market Closed
Market Cap: 1.5T KRW

HK Inno.N Corp
Current Portion of Long-Term Debt

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

HK Inno.N Corp
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
H
HK Inno.N Corp
KOSDAQ:195940
Current Portion of Long-Term Debt
â‚©22.6B
CAGR 3-Years
-47%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Current Portion of Long-Term Debt
â‚©19.7B
CAGR 3-Years
-5%
CAGR 5-Years
6%
CAGR 10-Years
15%
SK Biopharmaceuticals Co Ltd
KRX:326030
Current Portion of Long-Term Debt
â‚©33B
CAGR 3-Years
82%
CAGR 5-Years
54%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Current Portion of Long-Term Debt
â‚©36.5B
CAGR 3-Years
-26%
CAGR 5-Years
-23%
CAGR 10-Years
-2%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Current Portion of Long-Term Debt
â‚©17.6B
CAGR 3-Years
-6%
CAGR 5-Years
8%
CAGR 10-Years
N/A
C
Caregen Co Ltd
KOSDAQ:214370
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

HK Inno.N Corp
Glance View

Market Cap
1.5T KRW
Industry
Pharmaceuticals

HK inno.N Corp. engages in the provision of healthcare services. The company is headquartered in Chungju, Chungcheongbuk-Do. The company went IPO on 2021-08-09. The firm operates its business through three segments. The Prescription Drug segment is engaged in the manufacture and sale of hormone drugs, anticancer drugs, high blood pressure drugs, gastroesophageal reflux disease drugs, blood nutrient supplies, the circulatory system and others. The Health Beauty and Beverage (HB&B) segment is engaged in the manufacture and sale of products such as hangover relieving products, as well as health drinks and food products. The Other segment is engaged in the trademark royalties business and other services. The firm sells its products within domestic market and to overseas markets.

Intrinsic Value
67 869.95 KRW
Undervaluation 24%
Intrinsic Value
Price
H

See Also

What is HK Inno.N Corp's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
22.6B KRW

Based on the financial report for Dec 31, 2024, HK Inno.N Corp's Current Portion of Long-Term Debt amounts to 22.6B KRW.

What is HK Inno.N Corp's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
-28%

Over the last year, the Current Portion of Long-Term Debt growth was -87%. The average annual Current Portion of Long-Term Debt growth rates for HK Inno.N Corp have been -47% over the past three years , -28% over the past five years .

Back to Top